Thank you to Janison management for disclosing so much useful data so early after the end of FY.
There were a couple of negatives that I will get over first:
- EBITDA declined by half since FY21 from $3M to $1.5M. It was also lower than the previous 2 FYs.
- H2 FY22 revenue of $16.6M was $2.9M lower than H1 FY22 revenue (it should be noted however that for each of the last 3 FYs, H2 revenue has been lower than H1 revenue).
- Operating expenses grew faster than revenue, which is the reason why EBITDA declined.
IMO, the positives far outweigh the above negatives:
- Janison has introduced a more streamlined operating model with material cost-out starting 1 July 2022. There will be a material improvement in the cost base for FY23. It is also a nimbler organisation.
- The Cost of Sales declined in FY22, from $13.5M to $13.1M, meaning that all of the additional $6M revenue went straight to Gross Profit. Gross Profit rose by 37.7% to $23M. In only 2 years, Gross Profit has more than doubled from $10.1M to $23M. This is why Gross Margin has grown so quickly to 63.7%. This is one of the best features of Janison's business - the relatively fixed Cost of Sales through its scalable platform.
- Apart from the normal organic growth in revenue that Janison is experiencing, Janison can expect the following growth: An additional Pro-forma $1.8M from the 2 acquisitions over a full year; recovery of some of the covid impacts of around 10% of revenue; $1.15M pa from the 2 new significant contracts (Cambridge Box Hill and ACECQA). Even if they only recover half of the covid impacts in FY23, the total of all of this is around $5M, or around 14%. Organic growth is on top of this.
- The ICAS underlying growth rate was 50% in the lead-up to school closures last year. Schools are increasingly being removed from the sales process for ICAS, a big positive given the shortage of school administration resources. PISA growth was 47% in FY22. Higher education has signalled a return to exams operated by JEM. There is a robust pipeline of new platform clients.
- The domestic launch of the new school parent SaaS product RiSE+ is highly significant, with > 100,000 parents contacts already captured.
Outlook for FY23 (my opinion only, but entirely based on the comments made by Janison's management):
- Revenue growth of 20%, or by $7.2M to $43.2M (I believe this is very conservative - see item 3 above);
- 90% of the additional revenue goes to Gross Profit, which therefore increases by $6.5M to $29.5M (In FY22, all of the additional revenue went to Gross Profit);
- Operating expenses also remain steady based on Janison's statements above about a "material improvement in the cost base". This would mean that all of the additional Gross Profit goes straight to the EBITDA, which would therefore increase from $1.5M to $8M.
- Forums
- ASX - By Stock
- JAN
- Ann: JAN FY22 Trading Update
JAN
janison education group limited
Add to My Watchlist
0.00%
!
14.5¢

Ann: JAN FY22 Trading Update, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.68M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 128462 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.0¢ | 7198 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 128462 | 0.145 |
3 | 50530 | 0.140 |
3 | 71000 | 0.135 |
3 | 70040 | 0.130 |
1 | 2076 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.150 | 7198 | 3 |
0.155 | 79065 | 2 |
0.160 | 69929 | 3 |
0.165 | 58000 | 1 |
0.170 | 66286 | 2 |
Last trade - 10.03am 01/07/2025 (20 minute delay) ? |
Featured News
JAN (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Dr. Hartley Atkinson, MD
Dr. Hartley Atkinson
MD
Previous Video
Next Video
SPONSORED BY The Market Online